AllSight
Companies · CYRX · Pharmaceutical Preparations

Cryoport, Inc. (CYRX)

Cryoport, Inc. (CYRX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Cryoport, Inc. (CYRX) stock — financials & valuation

Key numbers for Cryoport, Inc. (CYRX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 36/100 — a percentile rank of Cryoport, Inc.’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.

Market cap$879.3M
P / S4.7×
EV / EBITDA-57.6×
Gross margin47.1%
Operating margin-21.2%
Net margin-20.1%
Return on equity-9.2%
ROIC-10.3%
Revenue growth12.1%
Debt / equity0.4×
Dividend yield0.0%

Is Cryoport, Inc. overvalued? P/S looks overvalued vs its 5-year range; P/B looks fair vs its 5-year range.

Independent of the events above — derived from Cryoport, Inc.’s own financial statements and shown as context, never as advice.

Aug 6, 2026In line
Cryoport posts revenue beat and first positive EBITDA, but margins still slide
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact